Rewarding properties of sildenafil citrate in mice: Role of the nitric oxide-cyclic GMP pathway

Psychopharmacology

Volumn 185, Issue 2, 2006, Pages 201-207

  Tahsili Fahadan, Pouya ^a,c   Yahyavi Firouz Abadi, Noushin ^a,b,c   Orandi, Amir Hossein ^a,c   Esmaeili, Behnaz ^a,c   Basseda, Zahra ^a,c   Dehpour, Ahmad Reza ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Conditioned place preference; Cyclic GMP; Mice; Nitric oxide; Sildenafil

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CONDITIONING; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; ERECTILE DYSFUNCTION; MOUSE; NONHUMAN; PLACE PREFERENCE; PRESCRIPTION; PRIORITY JOURNAL; REWARD; STIMULUS RESPONSE;

ANIMALS; ARGININE; CONDITIONING (PSYCHOLOGY); CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANYLATE CYCLASE; MALE; METHYLENE BLUE; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; REWARD;

EID: 33644837763     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0302-2     Document Type: Article

References (46)

1. Aldridge J, Measham F (1999) Sildenafil (Viagra) is used as a recreational drug in England. BMJ 318:669
2. Ambriz-Tututi M, Velazquez-Zamora DA, Urquiza-Marin H, Granados-Soto V (2005) Analysis of the mechanism underlying the peripheral antinociceptive action of sildenafil in the formalin test. Eur J Pharmacol 512:121-127
3. Belzung C, Barreau S (2000) Differences in drug-induced place conditioning between BALB/c and C57B1/6 mice. Pharmacol Biochem Behav 65:419-423
4. Boyce EG, Umland EM (2001) Sildenafil citrate: a therapeutic update. Clin Ther 23:2-23
5. Bredt DS, Hwang PM, Snyder SH (1990) Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347:768-770
6. Crosby R, Diclemente RJ (2004) Use of recreational Viagra among men having sex with men. Sex Transm Infect 80:466-468
7. Delate T, Simmons VA, Motheral BR (2004) Patterns of use of sildenafil among commercially insured adults in the United States: 1998-2002. Int J Impot Res 16:313-318
8. Ferrari F, Ottani A, Giuliani D (2002) Influence of sildenafil on central dopamine-mediated behaviour in male rats. Life Sci 70:1501-1508
9. Fricchione G, Stefano GB (2005) Placebo neural systems: nitric oxide, morphine and the dopamine brain reward and motivation circuitries. Med Sci Monit 11:54-65
10. Garthwaite J, Boulton CL (1995) Nitric Oxide signaling in the central nervous system. Annu Rev Physiol 57:683-706
11. Gerlach M, Blum-Degen D, Ransmayr G, Leblhuber F, Pedersen V, Riederer P (2001) Expression, but not activity, of neuronal nitric oxide synthase is regionally increased in the alcoholic brain. Alcohol Alcohol 36:65-69
12. Goldstein I (1999) A 36-week, open label, non-comparative study to assess the long-term safety of sildenafil citrate (Viagra) in patients with erectile dysfunction. Int J Clin Pract 102:8-9
13. Gracy KN, Pickel VM (1997) Ultrastructural localization and comparative distribution of nitric oxide synthase and N-methyl-D-aspartate receptors in the shell of the rat nucleus accumbens. Brain Res 747:259-272
14. Hotchkiss AK, Pyter LM, Gatien ML, Wen JC, Milman HA, Nelson RJ (2005) Aggressive behavior increases after termination of chronic sildenafil treatment in mice. Physiol Behav 83:683-688
15. Itzhak Y, Martin JL (2000) Blockade of alcohol-induced locomotor sensitization and conditioned place preference in DBA mice by 7-nitroindazole. Brain Res 858:402-407
16. Itzhak Y, Martin JL, Black MD, Huang PL (1998) The role of neuronal nitric oxide synthase in cocaine-induced conditioned place preference. Neuroreport 9:2485-2488
17. Jain NK, Patil CS, Singh A, Kulkarni SK (2001) Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res 909:170-178
18. Kim HS, Park WK (1995) Nitric oxide mediation of cocaine-induced dopaminergic behaviors: ambulation-accelerating activity, reverse tolerance and conditioned place preference in mice. J Pharmacol Exp Ther 275:551-557
19. Kivastik T, Rutkauskaite J, Zharkovsky A (1996) Nitric oxide synthesis inhibition attenuates morphine-induced place preference. Pharmacol Biochem Behav 53:1013-1015
20. Kurt M, Bilge SS, Aksoz E, Kukula O, Celik S, Kesim Y (2004) Effect of sildenafil on anxiety in the plus-maze test in mice. Pol J Pharmacol 56:353-357
21. Langroudi RM, Khoshnoodi MA, Abadi NY, Fahadan PT, Ghahremani MH, Dehpour AR (2005) Effect of cyclosporine A on morphine-induced place conditioning in mice: involvement of nitric oxide. Eur J Pharmacol 507:107-115
22. Li SM, Yin LL, Shi J, Lin ZB, Zheng JW (2002) The effect of 7-nitroindazole on the acquisition and expression of D-methamphetamine-induced place preference in rats. Eur J Pharmacol 435:217-223
23. Manzanedo C, Aguilar MA, Rodriguez-Arias M, Navarro M, Minarro J (2004) 7-Nitroindazole blocks conditioned place preference but not hyperactivity induced by morphine. Behav Brain Res 150:73-82
24. Marmor MF, Kessler R (1999) Sildenafil (Viagra) and Ophthalmology. Surv Ophthalmol 44:153-162
25. Martin JL, Itzhak Y (2000) 7-Nitroindazole blocks nicotine-induced conditioned place preference but not LiCl-induced conditioned place aversion. Neuroreport 11:947-949
26. Miliaressis E, Merali Z (1979) Alteration of cyclic nucleotide levels in brain following intracranial self-stimulation in the rat. Pharmacol Biochem Behav 11:107-110
27. Milman HA, Arnold SB (2002) Neurologic, psychological, and aggressive disturbances with sildenafil. Ann Pharmacother 36:1129-1134
28. Mixcoatl-Zecuatl T, Aguirre-Banuelos P, Granados-Soto V (2000) Sildenafil produces antinociception and increases morphine antinociception in the formalin test. Eur J Pharmacol 400:81-87
29. Miyamoto Y, Noda Y, Komori Y, Sugihara H, Furukawa H, Nabeshima T (2000) Involvement of nitric oxide in phencyclidine-induced place aversion and preference in mice. Behav Brain Res 116:187-196
30. Moncada S, Higgs EA (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012
31. Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathology, and pharmacology. Pharmacol Rev 43:109
32. Moreira SG, Brannigan RE, Spitz A, Orejuela FJ, Lipshultz LI, Kim ED (2000) Side-effect profile of sildenafil citrate (Viagra) in clinical practice. Urology 56:474-476
33. Osterloh I, Collins M, Wicker P, Wagner G (1999) Sildenafil citrate (Viagra): overall safety profile in 18 double-blind controlled, clinical trials. Int J Clin Pract 102:3-5
34. Pogun S, Baumann MH, Kuhar MJ (1994) Nitric oxide inhibits [3H] dopamine uptake. Brain Res 28:83-91
35. Pudiak CM, Bozarth MA (1997) Nitric oxide synthesis inhibition attenuates haloperidol-induced supersensitivity. J Psychiatry Neurosci 22:61-64
36. Pulvirenti L, Balducci C, Koob GF (1996) Inhibition of nitric oxide synthesis reduces intravenous cocaine self-administration in the rat. Neuropharmacology 35:1811-1814
37. Rodrigo J, Springall DR, Uttenthal O, Bentura ML, Abadia-Molina F, Riveros-Moreno V, Martinez-Murillo R, Polak JM, Moncada S (1994) Localization of nitric oxide synthase in the adult rat brain. Philos Trans R Soc Lond B Biol Sci 345:175-221
38. Romanelli F, Smith KM (2004) Recreational use of sildenafil by HIV-positive and -negative homosexual/bisexual males. Ann Pharmacother 38:1024-1030
39. Sahraei H, Pirzadeh-Jahromi G, Noorbakhshnia M, Asgari A, Haeri-Rohani A, Khoshbaten A et al (2004) Involvement of nucleus accumbens in L-arginine-induced conditioned place preference in rats. Behav Pharmacol 15:473-480
40. Smith KM, Romanelli F (2005) Recreational use and misuse of phosphodiesterase 5 inhibitors. J Am Pharm Assoc 45:63-72
41. Swearingen S, Klausner JD (2005) Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection. Am J Med 118:571-577
42. Snyder SH, Bredt DS (1991) Nitric oxide as a neural messenger. Trends Pharmacol Sci 12:125-128
43. Tzschentke TM, Schmidt WJ (1997) Interaction of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and conditioning behavioural sensitization. Behav Brain Res 84:99-107
44. Young J (1999) Sildenafil citrate (Viagra) in the treatment of erectile dysfunction: a 12-week, flexible-dose study to assess efficacy and safety. Int J Clin Pract 102:6-7
45. Zhang R, Wang Y, Zhang L, Zhang Z, Tsang W, Lu M, et al (2002) Recovery after stroke in rats. Stroke 33:2675-2680
46. Zhu XZ, Luo LG (1992) Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J Neurochem 59:932-935